MedPath

Effect of turmeric extract in patients with colon cancer

Phase 2
Not yet recruiting
Conditions
Health Condition 1: C188- Malignant neoplasm of overlappingsites of colon
Registration Number
CTRI/2022/09/045377
Lead Sponsor
JIPMER Intramural fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient of age >18 years of age, diagnosed de novo or recurrent metastatic colorectal cancer and planned to be started with first-line CAPOX regimen, ECOG performance status <2

Exclusion Criteria

Patients with human immunodeficiency virus, hepatitis B, or Hepatitis C infection

Pregnant or lactating women

Impaired renal function defined as creatinine >1.5 mg/dl Upper normal limit (UNL)

Impaired hematological function defined by ANC <1.5 L; platelet count ââ?°Â¤ 100Ã?â??109/L, hemoglobin ââ?°Â¤ 9 g/dl

Impaired liver function is defined as AST & ALT ââ?°Â¥ 2.5 Ã?â?? UNL, total serum bilirubin ââ?°Â¥1.5 UNL, Alkaline phosphatase ââ?°Â¥ 2.5 Ã?â?? UNL

Significant cardiovascular disease defined as LVEF < 50%/ myocardial infarction/stroke within the last 6 months, NYHA Class � 3 heart failure, history of QT prolongation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath